These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1158324)

  • 1. [Gastrointestinal absorption in the rat of anisole, trans-anethole, butylhydroxyanisole and safrole].
    Fritsch P; de Saint Blanquat G; Derache R
    Food Cosmet Toxicol; 1975 Jun; 13(3):359-63. PubMed ID: 1158324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of anisole, anethole, butylhydroxyanisole and safrole on intestinal absorption in the rat (author's transl)].
    Fritsch P; Lamboeuf Y; de Saint Blanquat G
    Toxicology; 1975 Jul; 4(3):341-6. PubMed ID: 1154431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
    Swanson AB; Miller EC; Miller JA
    Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
    Randerath K; Haglund RE; Phillips DH; Reddy MV
    Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
    Phillips DH; Reddy MV; Randerath K
    Carcinogenesis; 1984 Dec; 5(12):1623-8. PubMed ID: 6499113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, metabolism and excretion of safrole in the rat and man.
    Benedetti MS; Malnoë A; Broillet AL
    Toxicology; 1977 Feb; 7(1):69-83. PubMed ID: 14422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
    Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of butylated hydroxyanisole and butylated hydroxytoluene in rabbits.
    El-Rashidy R; Niazi S
    J Pharm Sci; 1980 Dec; 69(12):1455-7. PubMed ID: 7463340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution and pharmacokinetics of 3H-butylated hydroxyanisole in female mice.
    Taylor MJ; Sharma RP; Bourcier DR
    Agents Actions; 1984 Oct; 15(3-4):454-8. PubMed ID: 6524531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and metabolism of 2-t-butyl-4-methoxyphenol in the everted rat gut preparation.
    Della Corte L; Giovannini MG; Sgaragli GP
    Arch Toxicol Suppl; 1984; 7():307-10. PubMed ID: 6595997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of butylated hydroxyanisole and its conjugates in the tissues of rats.
    Minegishi K; Watanabe M; Yamaha T
    Chem Pharm Bull (Tokyo); 1981 May; 29(5):1377-81. PubMed ID: 7296706
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of protein deficiency and Tween 60 on the pharmacokinetics of butylated hydroxyanisole and metabolites in male Sprague-Dawley rats.
    Kangsadalampai K; Sharma RP; Taylor MJ; Salunkhe DK
    Drug Nutr Interact; 1986; 4(3):289-97. PubMed ID: 3956389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of safrole in the rat.
    Klungsøyr J; Scheline RR
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):211-6. PubMed ID: 6846029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of percutaneous absorption of fragrances by humans and monkeys.
    Bronaugh RL; Stewart RF; Wester RC; Bucks D; Mailbach HI; Anderson J
    Food Chem Toxicol; 1985 Jan; 23(1):111-4. PubMed ID: 4038674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The occurrence of glucuroconjugated metabolites of safrole in the urine of treated rats].
    Levi P; Janiaud P; Delaforge M; Morizot JP; Maume BF; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(5):1034-40. PubMed ID: 146545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
    Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
    Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of trans-anethole, estragole, eugenol, and safrole in the Ames Salmonella typhimurium assay.
    To LP; Hunt TP; Andersen ME
    Bull Environ Contam Toxicol; 1982 Jun; 28(6):647-54. PubMed ID: 7049270
    [No Abstract]   [Full Text] [Related]  

  • 18. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues.
    Wiseman RW; Fennell TR; Miller JA; Miller EC
    Cancer Res; 1985 Jul; 45(7):3096-105. PubMed ID: 4005847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Properties of the safrole metabolite-cytochrome P-450 complex.
    Elcombe CR; Bridges JW; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R72. PubMed ID: 1143487
    [No Abstract]   [Full Text] [Related]  

  • 20. A new metabolite of butylated hydroxyanisole in man.
    El-Rashidy R; Niazi S
    Biopharm Drug Dispos; 1983; 4(4):389-96. PubMed ID: 6661516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.